Last edition
News about Industrial talks
India Ratings and Research (Ind-Ra) has retained a neutral outlook on India’s pharmaceutical sector for FY27, projecting revenue growth of around 10 percent year on year. The growth is expected to be driven by sustained domestic demand and rising momentum in the contract development and manufacturing organisation segment.
Industrial talks | 19/02/2026 | By Darshana | 191
Daiichi Sankyo Submits sNDA in Japan for Datroway in First-Line Metastatic TNBC
Daiichi Sankyo files supplemental application in Japan for Datroway as a first-line treatment for metastatic triple negative breast cancer based on phase III trial data.
Industrial talks | 13/02/2026 | By News Bureau | 199
Sanofi Removes CEO Paul Hudson Amid Stalled Turnaround
Sanofi has removed chief executive officer Paul Hudson following a stalled turnaround effort and growing pressure around the performance of its vaccine business, marking a significant leadership shift at the French pharmaceutical major.
Industrial talks | 12/02/2026 | By Darshana | 205
Ribo and Madrigal Enter Global Licensing Deal for siRNA Programmes Targeting MASH
Suzhou Ribo Life Science and Madrigal Pharmaceuticals have signed a worldwide licensing agreement covering six pre-clinical siRNA programmes for metabolic dysfunction-associated steatohepatitis, with potential milestone payments of up to USD 4.4 billion.
Industrial talks | 12/02/2026 | By News Bureau | 268
Genesys Spine Reports Positive Multicentre Study Results for SIros SI Joint Fusion System
Prospective multicentre data show significant pain reduction, improved function and strong fusion outcomes with the SIros Lateral Sacroiliac Joint Fusion System.
Industrial talks | 09/02/2026 | By News Bureau | 123
UK MHRA Updates Safety Information on Semaglutide Over Rare NAION Vision Risk
UK MHRA flags a very rare risk of NAION linked to semaglutide, urging patients to seek immediate medical attention for sudden changes in vision.
Industrial talks | 07/02/2026 | By News Bureau | 603
Entod Pharmaceuticals Backs Global Push to Prevent Childhood Blindness at UK House of Lords
Entod Pharmaceuticals representatives participate in global discussions at the UK House of Lords to advance prevention-led strategies against childhood blindness, with a focus on ROP screening in India.
Industrial talks | 05/02/2026 | By News Bureau | 130
Sanofi Announces Euro 1 Billion Share Buyback Programme for 2026
R&D-driven biopharma major Sanofi to repurchase shares worth up to Euro 1 billion between February and December 2026, reinforcing its capital allocation strategy and long-term growth outlook.
Industrial talks | 04/02/2026 | By News Bureau | 378
The FDA has granted Priority Review to Datroway for first-line treatment of metastatic triple-negative breast cancer patients ineligible for immunotherapy, with a regulatory decision expected in Q2 2026.
Industrial talks | 04/02/2026 | By News Bureau | 180
Union Budget Boosts Pharma with Biopharma Shakti with Outlay of INR 10,000 Crore
Union Finance Minister Nirmala Sitharaman unveiled multiple initiatives for pharma and life sciences in budget 2026–27, including Biopharma Shakti, NIPER expansion, CDSCO strengthening and new investments, to position India as a global biopharma hub.
Industrial talks | 01/02/2026 | By News Bureau | 295
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy